Will cases of leprosy reaction increase with COVID-19 infection?
Saved in:
Main Authors: | Douglas Eulálio Antunes (Author), Isabela Maria Bernardes Goulart (Author), Luiz Ricardo Goulart (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is there a lack of a glucose monitoring and management protocol for preventing hyperglycemia and glucocorticoid-induced diabetes mellitus in leprosy reactions?
by: Douglas Eulálio Antunes, et al.
Published: (2024) -
Adverse reactions induced by MDT/WHO (Rifampicin+Clofazimine+Dapsone) and ROM (Rifampicin+Ofloxacin+Minocycline) regimens used in the treatment of leprosy: a cohort study in a National Reference Center in Brazil
by: Isadora Costa Celestino, et al.
Published: (2024) -
Revisiting primary neural leprosy: Clinical, serological, molecular, and neurophysiological aspects.
by: Diogo Fernandes Dos Santos, et al.
Published: (2017) -
Molecular, immunological and neurophysiological evaluations for early diagnosis of neural impairment in seropositive leprosy household contacts.
by: Diogo Fernandes Dos Santos, et al.
Published: (2018) -
Assessment of neuropathic pain in leprosy patients with relapse or treatment failure by infrared thermography: A cross-sectional study.
by: Liliane Marques de Pinho Tiago, et al.
Published: (2021)